TEVA icon

Teva Pharmaceuticals
TEVA

Overview Fund Trends Analyst Outlook Journalist POV

556 hedge funds and large institutions have $13.7B invested in Teva Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 172 increasing their positions, 170 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less call options, than puts

Call options by funds: $ | Put options by funds: $

2.94% less ownership

Funds ownership: 65.51% → 62.56% (-2.9%)

13% less funds holding in top 10

Funds holding in top 10: 16 → 14 (-2)

15% less capital invested

Capital invested by funds: $16.2B → $13.7B (-$2.5B)

Holders
556
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
14
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$596M
Puts
$625M
Net Calls
Net Calls Change

Top Buyers

1
+$183M
2
+$104M
3
+$84.5M
4
BMO
Beck Mack & Oliver
New York
+$64.5M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$49.4M

Top Sellers

1
-$466M
2
-$281M
3
-$162M
4
Franklin Resources
Franklin Resources
California
-$123M
5
Millennium Management
Millennium Management
New York
-$105M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$74.7M
27
$64.9M
28
$64.5M
29
$62.6M
30
$62M
31
$61.6M
32
$61.2M
33
$58.7M
34
$58M
35
$50.6M
36
$50.4M
37
$47.2M
38
$45.1M
39
$44.8M
40
$44M
41
$43.5M
42
$42.7M
43
$42.7M
44
$42.2M
45
$41.1M
46
$40.2M
47
$39.1M
48
$38M
49
$37.6M
50
$36.4M
1
2
3 4 5